Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

B27+ disease versus B27- disease.

A Linssen1

  • 1Netherlands Ophthalmologic Research Institute, Amsterdam.

Scandinavian Journal of Rheumatology. Supplement
|January 1, 1990
PubMed
Summary

Human Leukocyte Antigen B27 (HLA-B27) influences disease presentation, with B27-positive conditions showing earlier onset and specific complications. However, HLA-B27 is not the sole factor in disease development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of dopamine D2/D3 receptor antagonism on human planning and spatial working memory.

Translational psychiatry·2017
Same author

Rhemulatologists' performance in dailiy practice.

Arthritis and rheumatism·2001
Same author

Outcomes of HLA-B27-positive and HLA-B27-negative acute anterior uveitis.

American journal of ophthalmology·1995
Same author

Spondylarthropathy and selective IgA deficiency.

Rheumatology international·1995
Same author

[Diagnosis of systemic causes of uveitis; a matter for ophthalmologist and internist].

Nederlands tijdschrift voor geneeskunde·1994
Same author

Uveitis and systemic disease.

The British journal of ophthalmology·1992

Area of Science:

  • Immunogenetics
  • Rheumatology
  • Ophthalmology

Background:

  • The Human Leukocyte Antigen B27 (HLA-B27) gene is strongly associated with several inflammatory diseases.
  • Understanding the heterogeneity between HLA-B27-positive and HLA-B27-negative disease is crucial for diagnosis and treatment.

Purpose of the Study:

  • To investigate the distinct clinical patterns and associations in HLA-B27-positive versus HLA-B27-negative inflammatory diseases.
  • To elucidate the role of HLA-B27 as a genetic factor in disease expression.

Main Methods:

  • Comparative analysis of clinical data from patients with and without HLA-B27.
  • Review of disease associations, onset, clinical course, and specific complications.

Main Results:

  • HLA-B27-positive disease typically presents with earlier onset, more severe course, acute anterior uveitis, and peripheral arthritis.
  • HLA-B27-negative disease shows higher prevalence of psoriasis, inflammatory bowel disease, and erythema nodosum.
  • Family aggregation and male predominance are observed exclusively in HLA-B27-positive cases.
  • Significant overlap exists, with some cases being clinically indistinguishable.

Conclusions:

  • HLA-B27 significantly influences disease expression and clinical phenotype.
  • While HLA-B27 is an important genetic factor, it is not the sole determinant of pathogenesis in these diseases.
  • Further research is needed to identify other genetic and environmental factors contributing to disease development.

Related Experiment Videos